Global ENT Devices Market 2022-2028

September 2022 | 80 pages | ID: G7F1915550DCEN
Gen Consulting Company

Abstracts

The global ENT devices market is expected to increase by USD 3 billion, at a compound annual growth rate (CAGR) of 4.4% from 2022 to 2028, according to the latest edition of the Global ENT Devices Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global ENT devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the ENT devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for ENT devices can be segmented by product: diagnostic devices, hearing aid devices, hearing implants, speech aid devices, surgical devices. ENT devices market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:

• diagnostic devices
• hearing aid devices
• hearing implants
• speech aid devices
• surgical devices

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading ENT devices market vendors that include Cochlear Limited, Demant A/S, Hill-Rom Holdings, Inc., Honeywell International Inc., Hoya Corporation (PENTAX Medical), Johnson and Johnson, Karl Storz SE & Co. KG, Medtronic plc, Natus Medical Incorporated, Olympus Corporation, Smith & Nephew plc, Sonova Holding AG, Stryker Corporation, WS Audiology A/S, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global ENT devices market.
• To classify and forecast the global ENT devices market based on product, region.
• To identify drivers and challenges for the global ENT devices market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global ENT devices market.
• To identify and analyze the profile of leading players operating in the global ENT devices market.

Why Choose This Report

• Gain a reliable outlook of the global ENT devices market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Diagnostic devices
Hearing aid devices
Hearing implants
Speech aid devices
Surgical devices

PART 6. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 7. KEY COMPANIES

Cochlear Limited
Demant A/S
Hill-Rom Holdings, Inc.
Honeywell International Inc.
Hoya Corporation (PENTAX Medical)
Johnson and Johnson
Karl Storz SE & Co. KG
Medtronic plc
Natus Medical Incorporated
Olympus Corporation
Smith & Nephew plc
Sonova Holding AG
Stryker Corporation
WS Audiology A/S
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER